TNDM Q3 2023 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$186M-9.3% YoY

Gross Profit

$90M48.4% margin

Operating Income

-$32M-17.0% margin

Net Income

-$33M-17.8% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

-5.3%

Cash Flow

Operating Cash Flow

$55,000

Free Cash Flow

-$5M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$940M

Total Liabilities

$626M

Stockholders' Equity

$314M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$186M	$205M	-9.3%
Gross Profit	$90M	$104M	-14.1%
Operating Income	-$32M	-$47M	+33.6%
Net Income	-$33M	-$49M	+32.7%

Geographic Segments

UNITED STATES

$130M70%

Non-US

$55M30%